Elevated LDL cholesterol and increased risk of myocardial infarction and atherosclerotic cardiovascular disease in individuals aged 70–100 years: a contemporary …

MB Mortensen, BG Nordestgaard - The Lancet, 2020 - thelancet.com
Background Findings of historical studies suggest that elevated LDL cholesterol is not
associated with increased risk of myocardial infarction and atherosclerotic cardiovascular …

Total cholesterol and risk of mortality in the oldest old

AWE Weverling-Rijnsburger, GJ Blauw, AM Lagaay… - The Lancet, 1997 - thelancet.com
Background The impact of total serum cholesterol as a risk factor for cardiovascular disease
decreases with age, which casts doubt on the necessity for cholesterol-lowering therapy in …

Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials

B Gencer, NA Marston, KA Im, CP Cannon, P Sever… - The Lancet, 2020 - thelancet.com
Background The clinical benefit of LDL cholesterol lowering treatment in older patients
remains debated. We aimed to summarise the evidence of LDL cholesterol lowering …

[HTML][HTML] Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review

U Ravnskov, DM Diamond, R Hama, T Hamazaki… - BMJ open, 2016 - bmjopen.bmj.com
Objective It is well known that total cholesterol becomes less of a risk factor or not at all for all-
cause and cardiovascular (CV) mortality with increasing age, but as little is known as to …

Low-density lipoprotein cholesterol is predominantly associated with atherosclerotic cardiovascular disease events in patients with evidence of coronary …

MB Mortensen, O Dzaye, HE Bøtker, JM Jensen… - Circulation, 2023 - Am Heart Assoc
Background: Low-density lipoprotein cholesterol (LDL-C) is an important causal risk factor
for atherosclerotic cardiovascular disease (ASCVD). However, a sizable proportion of …

Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study

IJ Schatz, K Masaki, K Yano, R Chen, BL Rodriguez… - The lancet, 2001 - thelancet.com
Background A generally held belief is that cholesterol concentrations should be kept low to
lessen the risk of cardiovascular disease. However, studies of the relation between serum …

Effect of statin treatment vs usual care on primary cardiovascular prevention among older adults: the ALLHAT-LLT randomized clinical trial

BH Han, D Sutin, JD Williamson, BR Davis… - JAMA internal …, 2017 - jamanetwork.com
Importance While statin therapy for primary cardiovascular prevention has been associated
with reductions in cardiovascular morbidity, the effect on all-cause mortality has been …

Association between cumulative low-density lipoprotein cholesterol exposure during young adulthood and middle age and risk of cardiovascular events

Y Zhang, MJ Pletcher, E Vittinghoff… - JAMA …, 2021 - jamanetwork.com
Importance Low-density lipoprotein cholesterol (LDL-C) is a major risk factor for
cardiovascular disease (CVD). Most observational studies on the association between LDL …

[HTML][HTML] Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials

J Armitage, C Baigent, E Barnes, DJ Betteridge… - The Lancet, 2019 - thelancet.com
Background Statin therapy has been shown to reduce major vascular events and vascular
mortality in a wide range of individuals, but there is uncertainty about its efficacy and safety …

Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity

J Stamler, ML Daviglus, DB Garside, AR Dyer… - Jama, 2000 - jamanetwork.com
ContextBased on observational and interventional data for middle-aged cohorts (aged 40-
64 years), serum cholesterol level is known to be an established major risk factor for …